Please provide your email address to receive an email when new articles are posted on . Triptans and dihydroergotamine were not found to cause ischemic vascular events when used in the treatment of ...

The analysis included 64 randomized clinical trials with a total of 46,442 patients. Newer migraine pharmacotherapies appear to be less effective than triptans, according to findings from a systematic ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed 3,119,517 migraine attacks among 36,840 unique medication entries for 278,006 users.

October 24, 2006 — Overuse of ergotamine, but not overuse of triptans, increases the risk for ischemia in patients with migraines, according to the results of a retrospective, nested, case-control ...

Washington, DC — Patients with migraine do not take their prescribed triptan medications in more than two in every five attacks, a new study finds. Results from the largest-ever study to track ...

Migraine, a severe, throbbing pain, usually on one side of the head, is the leading cause of disability in girls and women aged 15 to 49 years. — TNS Some triptans are a more effective treatment for ...

Triptan use may be associated with a low increased risk for cerebral events, such as stroke, among older adults. Older adults prescribed second-generation serotonin 5HT1B/1D-receptor agonists ...

Triptans are a group of drugs targeted at alleviating symptoms of migraine, a severe and often debilitating headache that can affect sight and speech. The triptans available in Australia are: ...

Compared with triptan nonresponders, patients with migraine who report a response to at least 1 triptan have a higher likelihood of responding to treatment with erenumab, according to real-world data ...

The most effective triptans should be promoted globally and guidelines updated accordingly, say researchers. Some triptans are a more effective treatment for acute migraines than newer, more expensive ...